Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrous oxide augmentation for depressive disorder
RBR-5rz5chPhase 2Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of nitrous oxide in major depressive disorder (MDD) and major depressive episode (MDE) (2 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto. Started Jun 2016; status: completed.
02
Drugs
nitrous oxide
03
Conditions
major depressive disorder (MDD)major depressive episode (MDE)
Beyond the preview
Go deeper on RBR-5rz5ch.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5rz5ch.